Eva Ho
Finanzdirektor/CFO bei Crown Bioscience, Inc.
Profil
Eva Ho is currently the Chief Financial Officer at Crown Bioscience, Inc. She previously worked as the Chief Financial Officer & Spokesman at Acer, Inc. from 2012 to 2014.
She also held the position of Chief Financial Officer & Vice President at Test Rite International Co., Ltd.
and Chief Financial Officer at TWi Pharmaceuticals, Inc. Ms. Ho's education includes an MBA from the University of Denver and an undergraduate degree from National Taiwan University.
Aktive Positionen von Eva Ho
Unternehmen | Position | Beginn |
---|---|---|
Crown Bioscience, Inc.
Crown Bioscience, Inc. Miscellaneous Commercial ServicesCommercial Services Crown Bioscience, Inc. provides biomedical outsourcing solutions. It provides syngeneic and xenograft tumor models and custom model development and drug testing. The firm produces antibodies for therapeutic, diagnostic and theranostic applications. It also offers preclinical and drug development for anti-cancers therapeutics. The company was founded by Dr. Yiyou Chen, Dr. Yue Alexander Wu, Dr. William Pan and Dr. Faming Zhang in 2006 and is headquartered in Santa Clara, CA. | Finanzdirektor/CFO | 30.08.2016 |
Ehemalige bekannte Positionen von Eva Ho
Unternehmen | Position | Ende |
---|---|---|
ACER INCORPORATED | Finanzdirektor/CFO | 01.05.2014 |
CROWN BIOSCIENCE INTERNATIONAL | Finanzdirektor/CFO | - |
TWI PHARMACEUTICALS INC | Finanzdirektor/CFO | - |
TEST-RITE INTERNATIONAL CO., LTD. | Finanzdirektor/CFO | - |
Ausbildung von Eva Ho
National Taiwan University | Undergraduate Degree |
University of Denver | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
TEST-RITE INTERNATIONAL CO., LTD. | Distribution Services |
ACER INCORPORATED | Electronic Technology |
Private Unternehmen | 3 |
---|---|
TWi Pharmaceuticals, Inc.
TWi Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology TWi Pharmaceuticals, Inc. operates as a technology-based special pharmaceutical company. The firm engages in the development and commercialization of high barrier generics drugs. Its products include donepezil hydrochloride tablets, megestrol acetate oral suspension, hydroquinone cream, guanfacine extended-release tablets and nifedipine extended-release tablets. The company was founded by Chih Ming Chen on December 1, 1997 and is headquartered in Taipei, Taiwan. | Health Technology |
Crown Bioscience, Inc.
Crown Bioscience, Inc. Miscellaneous Commercial ServicesCommercial Services Crown Bioscience, Inc. provides biomedical outsourcing solutions. It provides syngeneic and xenograft tumor models and custom model development and drug testing. The firm produces antibodies for therapeutic, diagnostic and theranostic applications. It also offers preclinical and drug development for anti-cancers therapeutics. The company was founded by Dr. Yiyou Chen, Dr. Yue Alexander Wu, Dr. William Pan and Dr. Faming Zhang in 2006 and is headquartered in Santa Clara, CA. | Commercial Services |
Crown Bioscience International
Crown Bioscience International BiotechnologyHealth Technology Crown Bioscience International develops drug for Oncology and Metabolic Diseases. Its products include Antibodies for in vivo & in vitro studies, Tissues for CVMD research and therapeutic R&D, Recombinant cell lines, Tumor samples for oncology research & drug development. The company founded on October 22, 2013 and is headquartered in Taipei, Taiwan. | Health Technology |